In clinical practice, ABCD3-I score could be used for initial assessment for its easier evaluation method, and CSR model could stratify DWI-positive patients further based on detailed neuroimaging findings and determine individualized secondary prevention strategies for the purpose of reducing the risk of stroke after TIA. The gene discussed is ABCD3; the disease is stroke disorder.